TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
-5.63%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.54B
AUM Growth
+$2.54B
(-11%)
Cap. Flow
-$63M
Cap. Flow
% of AUM
-2.48%
Top 10 Holdings %
Top 10 Hldgs %
38.38%
Holding
180
New
5
Increased
28
Reduced
33
Closed
3
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$14.8M |
| 2 |
Intuitive Surgical
ISRG
|
$9.75M |
| 3 |
AstraZeneca
AZN
|
$8.86M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$8.43M |
| 5 |
Boston Scientific
BSX
|
$8.42M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$24M |
| 2 |
McKesson
MCK
|
$14.8M |
| 3 |
Eli Lilly
LLY
|
$11.5M |
| 4 |
Medtronic
MDT
|
$9.78M |
| 5 |
Waters Corp
WAT
|
$8.23M |
Sector Composition
| 1 | Healthcare | 95.42% |
| 2 | Real Estate | 3.13% |
| 3 | Industrials | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
NexGel
NXGL
$19.8M
| $7K | ﹤0.01% | 4,243 | – | – |
|
|
BLCM
177
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $7K | ﹤0.01% | 6,000 | – | – |
|
178
MoonLake Immunotherapeutics
MLTX
$3.54B
| – | – | -250,000 | Closed | -$2.78M |
|
179
Revvity
RVTY
$10.5B
| – | – | -33,444 | Closed | -$5.84M |
|
180
Dentsply Sirona
XRAY
$2.85B
| – | – | -57,400 | Closed | -$2.83M |
|